Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Deloitte
Cantor Fitzgerald
Cerilliant
US Army
Julphar
Farmers Insurance
Boehringer Ingelheim
Johnson and Johnson

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204147

« Back to Dashboard

NDA 204147 describes PROCHLORPERAZINE EDISYLATE, which is a drug marketed by Morton Grove, Athenex Inc, Emcure Pharms Ltd, Hospira, Marsam Pharms Llc, Smith And Nephew, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, and Alpharma Us Pharms, and is included in fifteen NDAs. It is available from four suppliers. Additional details are available on the PROCHLORPERAZINE EDISYLATE profile page.

The generic ingredient in PROCHLORPERAZINE EDISYLATE is prochlorperazine edisylate. There are twenty-one drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the prochlorperazine edisylate profile page.
Summary for 204147
Tradename:PROCHLORPERAZINE EDISYLATE
Applicant:Emcure Pharms Ltd
Ingredient:prochlorperazine edisylate
Patents:0
Therapeutic Class:Antiemetics
Antipsychotics
Formulation / Manufacturing:see details
Pharmacology for NDA: 204147
Ingredient-typePhenothiazines
Suppliers and Packaging for NDA: 204147
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 204147 ANDA Heritage Pharmaceuticals Inc. 23155-294 N 23155-294-41
PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 204147 ANDA Heritage Pharmaceuticals Inc. 23155-294 N 23155-294-42

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 5MG BASE/ML
Approval Date:Oct 15, 2013TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
US Army
Fuji
Boehringer Ingelheim
Accenture
Federal Trade Commission
QuintilesIMS
Moodys
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.